Nantes, France, April 15, 2026 – 7:30am CEST - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage ...

Scripps Research scientists have developed a new class of drug compounds that reduce harmful inflammation while leaving the ...

Scripps Research scientists have developed a new class of drug compounds that reduce harmful inflammation while leaving the ...

Add Yahoo as a preferred source to see more of our stories on Google. Pain pill graphic Today's painkillers are effective enough at doing their job, but carry the risk of side effects and negative ...

Researchers at Brigham and Women’s Hospital have identified a new class of small molecules that selectively shut down ...

Low-grade systemic inflammation across childhood and adolescence appears to increase the risk for onset of co-morbid mental health and cardiometabolic disorders in adulthood. Overall, 6556 ...

The MarketWatch News Department was not involved in the creation of this content. -- IND clearance enables initiation of U.S. Phase 2 clinical study in advanced periodontitis -- Targets upstream ...

New research is shedding light on surprising ways to reduce chronic inflammation—including suggestions as simple as flossing your teeth. From infrared saunas to meditation, there are several steps you ...

Targets upstream drivers of immune dysregulation in a disease affecting ~90 million Americans and over 1 billion people globally Potential to introduce a disease-modifying approach in a field ...